CoChat
Sign Up
Cited by 334Chronic Kidney Disease and DiabetesDialysis and Renal Disease ManagementDiet and metabolism studies

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study

Levey, Andrew S., Adler, Sharon, Caggiula, Arlene W., England, Brian K., Greene, Tom, Hunsicker, Lawrence G., Kusek, John W., Rogers, Nancy L., Teschan, Paul E.·1996·American Journal of Kidney Diseases
DOI 10.1016/s0272-6386(96)90099-2
Open this paper in CoChat — free account

Abstract

Patients with advanced renal disease randomized to the very low-protein diet group in the Modification of Diet in Renal Disease (MDRD) Study had a marginally (P = 0.066) slower mean glomerular filtration rate (GFR) decline compared with patients randomized to the low-protein diet group. The objective of these secondary analyses was to determine the relationship between achieved, in addition to prescribed, dietary protein intake and the progression of advanced renal disease. A randomized controlled trial was conducted in patients with chronic renal diseases of diverse etiology. The average follow-up was 2.2 years. Fifteen university hospital outpatient nephrology practices participated in the study, which comprised 255 patients aged 18 to 70 years with a baseline GFR 13 to 24 mL/min/1.73 m2 who participated in MDRD Study B. Patients with diabetes requiring insulin were excluded. The patients were given a low-protein (0.58 g/kg/d) or very low-protein (0.28 g/kg/d) diet supplemented with keto acids-amino acids (0.28 g/kg/d). Outcomes were measured by comparisons of protein intake from food or from food and supplement between randomized groups, and correlations of protein intake with rate of decline in GFR and time to renal failure or death. Comparison of the randomized groups showed that total protein intake from food and supplement was lower (P < 0.001) among patients randomized to the very low-protein diet (0.66 g/kg/d) compared with protein intake from food only in patients randomized to the low-protein diet (0.73 g/kg/d). In correlational analyses, we combined patients assigned to both diets and controlled for baseline factors associated with a faster progression of renal disease. A 0.2 g/kg/d lower achieved total protein intake (including food and supplement) was associated with a 1.15 mL/min/yr slower mean decline in GFR (P = 0.011), equivalent to 29% of the mean GFR decline. After adjusting for achieved total protein intake, no independent effect of prescription of the keto acid-amino acid supplement to slow the GFR decline could be detected. If the GFR decline is extrapolated until renal failure, a patient with a 29% reduction in the rate of GFR decline would experience a 41% prolongation in the time to renal failure. Additional analyses confirmed a longer time to renal failure in patients with lower total protein intake. In conclusion, these secondary analyses of the MDRD Study suggest that a lower protein intake, but not the keto acid-amino acid supplement, retards the progression of advanced renal disease. In patients with GFR less than 25 mL/min/1.73 m2, we suggest a prescribed dietary protein intake of 0.6 g/kg/d.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0272-6386(96)90099-2

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. 1994, J Am Soc Nephrol, 5, 335
  2. 1993, J Am Soc Nephrol, 4, 254

Cited by

Sorted by citations

See all 334

Related

See all

Metadata

Authors
Levey, A. S., Adler, S., Caggiula, A. W., England, B. K., Greene, T., Hunsicker, L. G., Kusek, J. W., Rogers, N. L., & Teschan, P. E.
Affiliations
National Institutes of Health (US)
ORCID
Venue
American Journal of Kidney Diseases
Publisher
Elsevier BV
Published
1996-05
Volume
27
Issue
5
Pages
652-663
ISSN
0272-6386 (ISSN-L)
DOI
10.1016/s0272-6386(96)90099-2
OpenAlex
W1995286167
Cited by
334
References
50
Citations by year
2026: 3 · 2025: 6 · 2024: 7 · 2023: 7 · 2022: 4 · 2021: 13 · 2020: 12 · 2019: 10 · 2018: 7 · 2017: 10 · 2016: 11 · 2015: 13 · 2014: 11 · 2013: 18 · 2012: 14
FWCI
16.72
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • American Journal of Kidney Diseases (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Pittsburgh
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
Keywords
protein restriction, very low protein diet, chronic kidney disease progression, glomerular filtration rate decline, MDRD Study, protein intake, renal failure, proteinuria, proteinuria reduction
MeSH terms
Adolescent, Adult, Aged, Amino Acids, Chronic Disease, Creatinine, Dietary Proteins, Female, Follow-Up Studies, Food, Fortified, Glomerular Filtration Rate, Humans, Keto Acids, Kidney Diseases, Male, Middle Aged, Proteinuria, Treatment Outcome, Disease Progression, Diet, Protein-Restricted, Renal Insufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review